A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The study is designed to assess the efficacy and safety of patient-initiated therapy with famciclovir 1500 mg o.d. or 750 mg b.i.d. for one day treatment in adult men and women with recurrent herpes labialis
Epistemonikos ID: 12370772b46ea66f6dffc8914af1e6aba889d254
First added on: May 04, 2024